Compare Stocks → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:KHRNTSE:LABSNYSE:RIVNASDAQ:XXII Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKHRNKhiron Life SciencesC$0.04C$0.04C$0.04▼C$0.21C$9.30M2.64256,268 shs24,000 shsLABSMediPharm LabsC$0.08-11.1%C$0.07C$0.06▼C$0.10C$32.10M1.04236,026 shs378,753 shsRIVRiverNorth Opportunities Fund$12.04+0.7%$11.70$9.63▼$12.43N/AN/A84,091 shs79,841 shsXXII22nd Century Group$0.12-7.7%$0.15$0.10▼$12.00$3.71M1.541.28 million shs3.46 million shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKHRNKhiron Life Sciences0.00%0.00%0.00%0.00%-27.27%LABSMediPharm Labs-5.26%+38.46%+38.46%+28.57%+28.57%RIVRiverNorth Opportunities Fund+0.42%+1.18%+2.13%+8.73%+8.24%XXII22nd Century Group+0.08%-5.60%-6.07%-31.51%-98.84%Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationKHRNKhiron Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ALABSMediPharm LabsN/AN/AN/AN/AN/AN/AN/AN/ARIVRiverNorth Opportunities FundN/AN/AN/AN/AN/AN/AN/AN/AXXII22nd Century Group2.3677 of 5 stars3.32.00.00.03.01.71.3Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKHRNKhiron Life SciencesN/AN/AN/AN/ALABSMediPharm LabsN/AN/AN/AN/ARIVRiverNorth Opportunities FundN/AN/AN/AN/AXXII22nd Century Group2.50Moderate Buy$6.255,108.33% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKHRNKhiron Life SciencesC$16.14M0.58C$0.01 per share6.67C$0.12 per share0.33LABSMediPharm LabsC$29.55M1.09C$0.06 per share1.30C$0.14 per share0.57RIVRiverNorth Opportunities Fund$-5.45MN/AN/AN/AN/AN/AXXII22nd Century Group$62.11M0.06N/AN/A$6.68 per share0.02Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKHRNKhiron Life Sciences-C$30.66M-C$0.17N/A∞N/A-190.00%-74.68%-20.79%N/ALABSMediPharm Labs-C$15.73M-C$0.05N/A∞N/A-53.23%-27.19%-17.79%N/ARIVRiverNorth Opportunities FundN/AN/A0.00∞N/AN/AN/AN/AN/AXXII22nd Century Group-$59.80M-$8.08N/AN/AN/A-167.13%-121.41%-74.82%3/28/2024 (Confirmed)Latest RIV, LABS, XXII, and KHRN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/28/2024N/AXXII22nd Century Group-$0.58-$0.55+$0.03N/AN/AN/A DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKHRNKhiron Life SciencesN/AN/AN/AN/AN/ALABSMediPharm LabsN/AN/AN/AN/AN/ARIVRiverNorth Opportunities Fund$1.5312.71%-10.79%N/A1 YearsXXII22nd Century GroupN/AN/AN/AN/AN/ALatest RIV, LABS, XXII, and KHRN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date1/2/2024RIVRiverNorth Opportunities Fundmonthly$0.128913.8%3/14/20243/15/20243/28/20241/4/2024RIVRiverNorth Opportunities Fundmonthly$0.128914%2/14/20242/15/20242/29/20241/2/2024RIVRiverNorth Opportunities FundMonthly$0.128913.97%2/14/20242/15/20242/29/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKHRNKhiron Life Sciences9.462.020.72LABSMediPharm Labs4.933.283.10RIVRiverNorth Opportunities FundN/AN/AN/AXXII22nd Century Group0.011.020.62OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKHRNKhiron Life Sciences0.22%LABSMediPharm Labs0.73%RIVRiverNorth Opportunities FundN/AXXII22nd Century Group18.06%Insider OwnershipCompanyInsider OwnershipKHRNKhiron Life Sciences4.64%LABSMediPharm Labs2.47%RIVRiverNorth Opportunities FundN/AXXII22nd Century Group0.40%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableKHRNKhiron Life SciencesN/A232.41 millionN/ANot OptionableLABSMediPharm Labs130401.28 millionN/ANot OptionableRIVRiverNorth Opportunities FundN/AN/AN/ANot OptionableXXII22nd Century Group19830.88 million30.75 millionOptionableRIV, LABS, XXII, and KHRN HeadlinesSourceHeadline22nd Century's losses continue to surge as it awaits potential FDA lifelinejournalnow.com - March 28 at 1:35 PMXXII Stock Earnings: 22nd Century Group Misses EPS, Misses Revenue for Q4 2023msn.com - March 28 at 1:35 PMNotable earnings before Thursday's openmsn.com - March 28 at 8:34 AMWhy RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarketbenzinga.com - March 28 at 8:34 AM22nd Century Group (XXII) Reports Fourth Quarter 2023 Financial Resultsnewsfilecorp.com - March 28 at 6:00 AM22nd Century Group (XXII) Set to Announce Quarterly Earnings on Thursdayamericanbankingnews.com - March 27 at 1:58 AMXXII May 2024 2.000 putfinance.yahoo.com - March 25 at 8:29 AMXXII Jan 2026 0.500 putfinance.yahoo.com - March 25 at 8:29 AMXXII Mar 2024 0.500 putfinance.yahoo.com - March 15 at 2:30 PM22nd Century Group to Announce Fourth Quarter 2023 Results on March 28, 2024newsfilecorp.com - March 15 at 8:00 AMXXII Jul 2024 1.000 callfinance.yahoo.com - March 5 at 2:05 AMZacks Industry Outlook Highlights Philip Morris International, Altria and 22nd Century Groupfinance.yahoo.com - February 26 at 10:58 AMMO Mar 2024 37.500 putca.finance.yahoo.com - February 25 at 8:14 PMSmall manufacturers forced to answer 300 questions on net zerofinance.yahoo.com - February 25 at 8:14 PMPM Mar 2024 91.000 putfinance.yahoo.com - February 25 at 1:35 AMThe scourge of fine print: Even Donald Trump’s new line of sneakers comes with caveats.finance.yahoo.com - February 24 at 12:29 PMStocks open higher coming off of Thursday's Nvidia rallyfinance.yahoo.com - February 24 at 12:29 PMMO Mar 2024 40.500 putsg.finance.yahoo.com - February 24 at 12:30 AMMO Mar 2024 31.000 callfinance.yahoo.com - February 24 at 12:10 AMMO Mar 2024 41.500 putca.finance.yahoo.com - February 23 at 9:18 PMMO Mar 2024 41.000 callca.finance.yahoo.com - February 23 at 9:18 PMMO Apr 2024 42.000 callfinance.yahoo.com - February 23 at 2:29 PMMO Apr 2024 41.000 putfinance.yahoo.com - February 23 at 2:29 PM3 Tobacco Stocks Grabbing Attention on Solid Industry Trendszacks.com - February 23 at 9:36 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlinesbluebird bio Stock Signals Potential to be a Multi-bagger February 29, 2024 9:55 AMView bluebird bio Stock Signals Potential to be a Multi-bagger Active Rebound: 2 Discrete Semiconductor Stocks Making MovesMarch 12, 2024 8:00 AMView Active Rebound: 2 Discrete Semiconductor Stocks Making MovesOracle's AI Cloud Demand Fuels Profitability SurgeMarch 14, 2024 1:17 PMView Oracle's AI Cloud Demand Fuels Profitability SurgePalantir Technologies: Bearish Sentiment, Bullish Chart SignalsMarch 27, 2024 7:30 AMView Palantir Technologies: Bearish Sentiment, Bullish Chart SignalsOracle Drives Next Era of AI Advancement: Stock Skyrockets by 15%March 12, 2024 9:30 AMView Oracle Drives Next Era of AI Advancement: Stock Skyrockets by 15%All Headlines Company DescriptionsKhiron Life SciencesCVE:KHRNKhiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.MediPharm LabsTSE:LABSMediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.RiverNorth Opportunities FundNYSE:RIVRiverNorth Opportunities Fund, Inc. is a close ended equity mutual fund co- launched and co- managed by ALPS Advisors, Inc. and RiverNorth Capital Management, LLC. It invests in the equity markets. The fund seeks to invest in stocks of companies operating across the diversified sectors. RiverNorth Opportunities Fund, Inc. was formed on December 24, 2015 and is domiciled in the United States.22nd Century GroupNASDAQ:XXII22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.